IFP Advisors, Inc - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$860
-78.8%
75
-50.0%
0.00%
Q2 2023$4,050
-93.2%
150
-92.8%
0.00%
-100.0%
Q1 2023$59,552
+2977500.0%
2,075
+2666.7%
0.00%
Q4 2022$2
-99.9%
75
-10.7%
0.00%
Q3 2022$3,0000.0%840.0%0.00%
Q2 2022$3,000
-50.0%
84
-50.0%
0.00%
Q1 2022$6,000
+500.0%
168
+124.0%
0.00%
Q4 2021$1,000
-97.0%
75
-94.0%
0.00%
-100.0%
Q2 2017$33,000
+57.1%
1,250
+25.0%
0.00%0.0%
Q1 2017$21,0001,000
+14185.7%
0.00%
Q4 2015$070.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders